Cutting Brand-Name Drug Use Could Save U.S. $73 Billion
The nation spends more on medications than any other country
Low-Dose Alteplase Not Noninferior for Ischemic Stroke
For primary outcome of death and disability at 90 days, low dose not noninferior to standard dose
Ticagrelor Doesn’t Beat Aspirin in Ischemic Stroke, TIA
Ticagrelor not superior to aspirin for reducing composite of stroke, myocardial infarction, death
CDC Updates Zika Testing Guidance for Urine Samples
CDC recs for Zika virus testing of serum and other clinical specimens remain unchanged at this time
CDC Establishes New ‘Clean Hands Count’ Campaign
Campaign urges health care professionals and patients and loved ones to keep hands clean
Exercise Reduces Fatigue, Depression, Paresthesia in MS
Females with multiple sclerosis report decreases with yoga, aquatic exercise versus non-exercise control
Preadmission SSRI Use Ups Stroke Mortality in Diabetes
Selective serotonin reuptake inhibitor use increases risk for patients hospitalized with stroke
Long-Term Warfarin Use Tied to Increased Dementia Risk
Both warfarin and atrial fibrillation may raise risk
New Evidence of Link Between Zika and Guillain-Barré
Sharp increase in the number of people in Brazil with Guillain-Barré since the Zika outbreak began
Long-Term Treatment Benefit Seen in Relapse-Onset MS
Disease-modifying therapy protects against disability accrual over 10-year period
